Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Profound & Tennr below!
Hit the Gong 🎉
Source: @overheard_sales
Daily Deals 💸
🌎 Americas
Abridge has developed a healthcare application to bring context and understanding to every medical conversation, enabling users to follow through with the doctors' recommendations and stay updated. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $300M, Series E
Round Investors: Andreessen Horowitz (lead), Khosla Ventures
🚀Growth Focus: Develop more features for its platform, specifically on easing the process of generating medical billing codes.
Press: SiliconANGLE, PYMNTS.com
HQ: San Francisco, CA
Industry: Hospitals and Health Care
Employee Count: 349 (⚡70% increase in last 6 months)
Neuron23 develops an AI-based drug discovery model for genetically defined neurological and immunological diseases, allowing patients suffering from genetic disorders to receive customized medicines. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $96.5M, Series D
Round Investors: Blue Owl, Westlake Village BioPartners, Acorn Bioventures, HBM Healthcare Investments
🚀 Growth Focus: Support the development of its lead candidate, NEU-411, a brain-penetrant oral LRRK2 inhibitor now being tested in Phase II for early-stage Parkinson's disease.
Press: Yahoo Finance, FirstWord Pharma
HQ: San Francisco, CA
Industry: Biotechnology Research
Employee Count: 42 (⚡21% increase in last 6 months)
Subscribe to TFL All-Access Tier to read the rest.
Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.
UpgradeA subscription gets you:
- Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
- Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
- The hottest Sales Gigs in the industry, sourced from the fastest growing startups
- ..and much more to come!